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Previewsinsulator (Xiao et al., 2011), suggesting
that they may contribute to the formation
of CTCF-mediated DNA loops (Dorsett,
2011). The formation of such loops en-
closing the Wnt4 locus may be the basis
for the functional chromatin domain es-
tablished by Wt1. Wt1-mediated chro-
matin- and gene-expression regulation is
limited to the region bound by the two
CTCF sites and does not affect the neigh-
boring Zbtb40 and Cdc42 genes that are
located on either side of the domain.
Indeed, if the boundaries of the domain
are disrupted through the reduction of
CTCF and/or cohesin, the transcription
of these two neighboring genes is induced
(Figure 1). This observation suggests that,
in the absence of CTCF, the active chro-
matin domain created by Wt1 in kidney
cells spreads outside of its normal bound-
aries and alters the transcription of neigh-
boring genes, with perhaps important
consequences for the viability or differ-
entiation of the affected cells. The first
CTCF insulator analyzed in vertebrates,
the chicken HS4 insulator element lo-
cated in the b-globin locus, shows only
enhancer-blocking insulator function
(Bell et al., 1999). The findings of Essafi390 Developmental Cell 21, September 13, 20et al. (2011) now convincingly demon-
strate that CTCF can also have barrier
insulator activity. Analysis of the basis
for these two different behaviors of
CTCF in different genomic and cell-type
contexts should give insights into the
mechanisms by which this protein af-
fects nuclear organization and gene
expression.
Recently, a high-resolution CTCF chro-
matin interactome map in mouse embry-
onic stem cells has identified 1480 cis-
and 336 trans-interacting loci (Handoko
et al., 2011). Up to 23% of all loops for-
med by these CTCF-mediated interac-
tions appear to separate domains of
active or repressive chromatin modifica-
tions. The nature and function of the
genes located in these domains has not
yet been analyzed. It will be interesting
to examine in future studies whether
domain-specific regulation of chromatin
structure, as shown by Essafi et al.
(2011) for epicardial and kidney mesen-
chymal cells, is a general mechanism
broadly used during cell differentiation.
Such mechanism would ensure coregula-
tion of genes present in a specific CTCF-
delimited domain.11 ª2011 Elsevier Inc.REFERENCES
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Nuclear spatial organization of genes has emerged as an important determinant of their transcriptional
activity. In this issue, Wang et al. (2011) show that the Msx1 homeoprotein induces a dramatic redistribution
of Ezh2 and H3K27me3 to the nuclear periphery of muscle progenitor cells to repress transcription of devel-
opmentally regulated genes.It is now established that mammalian
genomes take on a nonrandom spatial
organization in the nucleus that is both
dynamic and cell-type specific. Chromo-
somes, segments of the chromatin, or
individual gene loci adopt a highly orga-
nized structure and move between spa-
tially distinct chromosome territories
(Rajapakse and Groudine, 2011). Amongthese chromosome territories, the nuclear
lamina (or nuclear periphery) regroups
chromatin enriched for repressed genes
and represents 40% of the genome
(Peric-Hupkes et al., 2010), whereas RNA
Polymerase II-rich transcription factories
in the lumen are associatedwith highly ex-
pressed genes (Eskiw et al., 2010). How-
ever, it should be noted that genes onthe nuclear periphery are not always re-
pressed nor are genes in the lumen always
expressed (Meister et al., 2011).
Like chromatin, the distribution of
histone marks has also been observed
to change with cell identity. The transcrip-
tionally repressive lysine 27 trimethylation
mark on histone H3 (H3K27me3) is estab-
lished by the Ezh2 subunit of the PRC2
Figure 1. Msx1 Establishes Repression of the MyoD Gene through the Redistribution of
Ezh2-Containing PRC2 Complexes to the Nuclear Periphery
Spatial positioning of MyoD (and its transcriptional status) is shown in the nuclei of Msx1-expressing
myoblasts (left), normal myoblasts (center), and differentiating myotubes (right). In the nucleus of Msx1-
expressing myoblasts (left), Msx1 represses the transcription of its target genes (MyoD is shown in purple
as an example) by recruiting the PRC2 complex, leading to an enrichment of H3K27me3 at the nuclear
periphery. In normal myoblasts (center), MyoD is transcribed at a moderate rate but remains localized
to the nuclear periphery. However, in the absence of conditions favorable to myogenesis, the cells do
not differentiate as YY1 recruits the PRC2 to muscle differentiation genes (dark green) to mediate their
repression via H3K27 trimethylation (H3K27me3). Finally, under cellular conditions that are favorable to
myogenesis (right), MyoD moves toward the center of nucleus and becomes more heavily transcribed.
This leads to MyoD-dependent activation of muscle differentiation genes (dark green) through a displace-
ment of PRC2. At the same time, the PRC2 complex is then relocated to another set of genes (pink), such
as those involved in cell cycle progression, to repress the expression of genes that are no longer required
for muscle development.
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PreviewsPolycomb Group (PcG) complex, proteins
that are involved in the maintenance
of transcriptional repression at develop-
mentally regulated genes (Margueron
and Reinberg, 2011). Mouse embryonic
stem (ES) cells show an enrichment for
the H3K27me3 at the nuclear periphery,
whereas differentiated cells display a
more diffuse pattern of H3K27me3
throughout the nucleus (Luo et al., 2009).
These findings suggest that the spatial
organization of H3K27me3 within the
nucleus during differentiation has func-
tional significance, though the mecha-
nism by which H3K27me3 marks are re-
distributed in the nuclear space remains
unclear.
In this issue, Wang et al. (2011) provide
insight into the mechanism through which
H3K27me3 becomes enriched at the
nuclear lamina. Analyzing skeletal muscle
myoblasts and cells in murine limb buds,
the authors demonstrate that the expres-
sion of the homeoprotein Msx1 is suffi-
cient to induce a dramatic redistribution
of both Ezh2 and H3K27me3 to the
nuclear periphery. This redistribution of
H3K27me3 leads to repression of devel-
opmentally regulated Msx1 target genes
that are localized at the lamina. Inter-
estingly, the important accumulation ofH3K27me3 at the nuclear periphery is
not a result of global changes in
H3K27me3 levels. Instead, the enrich-
ment of H3K27me3 in the nuclear
periphery occurs through a redistribution
of Ezh2-induced H3K27me3 marks that
would normally localize to the nuclear
lumen in the absence of Msx1. The
authors alsodemonstrate that this redistri-
bution of H3K27me3 requires an interac-
tion between PRC2 and Msx1, as the
absence of either Ezh2 or Msx1 in the
cell prevents relocalization of Ezh2,
H3K27me3, or Msx1 to the nuclear
periphery. This finding suggests amecha-
nism of co-operative binding between
Msx1 and Ezh2 at target genes. Interest-
ingly, Wang and colleagues (2011) find
that this ability to redistribute H3K27me3
marks to the nuclear periphery is unique
to Msx1 among homeoproteins when
examined in the muscle cell context.
However, their data also show that cells
of the neural tube (which express en-
dogenous Msx1 and Ezh2) do not dis-
play a nuclear periphery organization of
H3K27me3, Msx1, or Ezh2. This suggests
the co-operative binding leading to this
redistribution also involves other factors.
It remains to be seen whether other tran-
scriptional repressors might possess aDevelopmental Cell 21, Sesimilar ability to redistribute Ezh2 and
H3K27me3 to the nuclear periphery
when provided with a proper cellular
context.
While current models for spatial organi-
zation in the nucleus propose that genes
move between chromosomal territories,
the findings of Wang et al. (2011) suggest
a mechanism in which Msx1/Ezh2 pro-
teins establish a H3K27me3-rich domain
at genes that are already present in the
nuclear periphery, rather than Msx1 dis-
placing its target genes to a pre-existing
Ezh2/H3K27me3-rich nuclear chromo-
some territory. To provide further evi-
dence for this, the authors examined the
master regulator gene MyoD, which is ex-
pressed from the nuclear periphery in
myoblasts and moves to the lumen upon
differentiation (Yao et al., 2011). They
show that expression of Msx1 in myo-
blasts does not affect localization of the
MyoD gene to the nuclear periphery
(Figure 1). Instead, Msx1 acts to repress
MyoD expression through the establish-
ment of the H3K27me3 mark in an Ezh2-
dependent manner, supporting the no-
tion that Msx1 promotes formation of an
H3K27me3-enriched compartment at
specific genes.
A question that remains unanswered is
how Msx1 hijacks the bulk of cellular
Ezh2 for its enrichment at the nuclear
periphery. Indeed, the drastic relocaliza-
tion of Ezh2 in myoblasts that is observed
in the presence of Msx1 suggests the
formation of a strong Ezh2/Msx1 inter-
action at the expense of interactions
with other partners. Consistent with this,
muscle-specific genes where Ezh2 is tar-
geted by the protein YY1 in proliferating
myoblasts (Caretti et al., 2004; Palacios
et al., 2010) display a decreased enrich-
ment of H3K27me3 upon exogenous
Msx1 expression. One possible explana-
tion for this observation is that the PRC2
complex has a stronger affinity for Msx1
compared to YY1. Alternatively, Msx1
expression may more directly result in
the downregulation of YY1 expression.
Finally, posttranslational modification of
Ezh2 (or another PRC2 subunit) could
modulate its ability to interact with alter-
native partners, as previously suggested
(Palacios et al., 2010). Future studies
are required to distinguish between these
possibilities to resolve the mechanism of
Ezh2 enrichment at the nuclear
periphery.ptember 13, 2011 ª2011 Elsevier Inc. 391
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PreviewsThis exciting study from Wang and
colleagues has provided us with insight
into the formation of the H3K27me3
mark at developmentally regulated genes.
Of particular note, Msx1 is expressed in
cells of the developing limb bud that
have not yet committed to the skeletal
muscle lineage. As H3K27me3 enrich-
ment at the nuclear periphery has previ-
ously been observed in ES cells, it will
be of interest to determine whether the
remarkable spatial reorganization of this
transcriptionally repressive mark is also
present in other multi-potent cell types.392 Developmental Cell 21, September 13, 20REFERENCES
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Continuous developmental maturation of cardiomyocytes is essential to meet the functional and metabolic
demands of the growing heart. A new study (Hom et al., 2011) reports that embryonic cardiomyocytes are
influenced by mitochondrial maturation, such that closure of the mitochondrial permeability transition pore
results in decreased levels of reactive oxygen species, thereby inducing differentiation.Unraveling the molecular program that
induces and establishes differentiation
and maturation of cardiomyocytes during
heart development is imperative for un-
derstanding the pathogenesis of pre-
and postnatal cardiac disease as well as
for therapeutic approaches aiming for
regeneration of damaged myocardium.
Although a multitude of transcription
factors and small molecules have been
identified that promote or inhibit cardio-
myogenesis, their precise interaction is
incompletely understood. This is compli-
cated by the fact that cardiomyocyte
differentiation is not only reflected by the
assembly of a contractile apparatus but
involves changes in cellular metabolism,
cell-cell communication, and organelle
structure. In this issue of Developmental
Cell, Hom et al. (2011) add another level
of complexity by reporting that cardio-
myocyte differentiation in the embryonic
heart is directly controlled by mitochon-drial maturation. The authors show that
mouse hearts at embryonic day (E) 9.5
contain relatively few and immature mito-
chondria, characterized by rare and disor-
ganized cristae. In E13.5 hearts, in con-
trast, the mitochondrial mass increases
substantially, accompanied by matura-
tion of the organelle as indicated by abun-
dant laminar cristae.
While these findings per se might be
regarded as a consequence (rather than
a cause) of cardiomyocyte differentiation
and could just reflect the increasing con-
tractile and therefore metabolic demands
of the developing heart, the authors
instead demonstrate that mitochondrial
maturation induces cardiomyocyte differ-
entiation. In vitro studies revealed that
cardiomyocytes from E9.5 hearts exhibit
a reduced mitochondrial membrane
potential as well as increased levels of
reactiveoxygen species (ROS)whencom-
pared to E13.5 cardiomyocytes. Thesefindings are characteristic for opening of
the mitochondrial permeability transition
pore (mPTP)within the innermitochondrial
membrane and suggest that the mPTP is
open in early embryonic cardiomyocytes
but closes upon developmental progres-
sion. Indeed, the authors could show that
closing the mPTP in E9.5 cardiomyocytes
by pharmacological or genetic manipula-
tions results in functional as well as
morphological maturation of mitochon-
dria. Importantly, closing the mPTP
induces differentiation of early (but not
late) cardiomyocytes, which is evident as
an increase in the number of sarcomeres
per cell. This effect is dependent on intra-
cellular ROS levels, which are high in
E9.5 cardiomyocytes but drop upon
physiological as well as induced closure
of the mPTP. The authors could show
that pharmacologically reducing ROS
levels in early cardiomyocytes mimics
the effect of mPTP closure and promotes
